SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094164
Filing Date
2024-08-08
Accepted
2024-08-08 17:01:23
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcab-20240630.htm   iXBRL 10-Q 1687122
2 EX-10.1 bcab-ex10_1.htm EX-10.1 23720
3 EX-10.2 bcab-ex10_2.htm EX-10.2 36814
4 EX-31.1 bcab-ex31_1.htm EX-31.1 15641
5 EX-31.2 bcab-ex31_2.htm EX-31.2 15593
6 EX-32.1 bcab-ex32_1.htm EX-32.1 14064
  Complete submission text file 0000950170-24-094164.txt   5935967

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bcab-20240630.xsd EX-101.SCH 894780
60 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20240630_htm.xml XML 759852
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39787 | Film No.: 241189445
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)